Phage therapy is an old method of combating bacterial pathogens that has recently been taken into consideration due to the alarming spread of antibiotic resistance. Escherichia coli O157:H7 is a foodborne pathogen that causes hemorrhagic colitis and life-threatening Hemolytic Uremic Syndrome (HUS). There are several studies on isolation of specific phages against E. coli O157:H7 and more than 60 specific phages have been published so far. Although in vitro experiments have been successful in elimination or reduction of E. coli O157:H7numbers, in vivo experiments have not been as promising. This may be due to escape of bacteria to locations where phages have difficulties to enter or due to the adverse conditions in the gastrointestinal tract that affect phage viability and proliferation. To get around the latter obstacle, an alternative phage delivery method such as polymer microencapsulation should be tried. While the present time results are not very encouraging the work should be continued as more efficient phage treatment regimens might be found in future.
Introduction
Although first indications of bacteriophages (bacterial viruses) were reported already in 1896 (Hankin, 1896) , bacteriophages were first time isolated in early 1900's (d 'Herelle, 1917; Twort, 1915) . Phages were used to treat infectious diseases in different parts of the world until late 1930s. The advent of antibiotics, improper use of phages and unstable formulations of phage particles reduced the use of phage therapy especially in Western countries (Bradbury, 2004) . In recent years, the emergence of antibiotic resistance in bacterial populations has encouraged researchers to find bacteriophages to combat bacterial infections (Deresinski, 2009) .
Escherichia coli O157:H7 that is present in the normal flora of livestock (Paton and Paton, 1998) can cause hemorrhagic colitis and lifethreatening HUS (Hemolytic Uremic Syndrome). Outbreaks of this pathogen can originate from meat, milk, vegetables and water (Ferens and Hovde, 2011) . There is a controversy about using antibiotics in treatment of E. coli O157:H7 infections as it is believed that use of certain antibiotics could induce the release of shiga toxins (Galland et al., 2001) . Clinical studies have demonstrated that antibiotic treatment can indeed increase the risk of HUS development (Wong et al., 2012) . In addition, antibiotic resistance among E. coli O157 isolates has increased. In one study, 21% of human clinical isolates of E. coli O157 were resistant to ampicillin, 12% to sulfamethoxazole, 15% to cephalothin, 12% to tetracycline, and 5% to trimethoprim-sulfamethoxazole (Schroeder et al., 2002) .
Specific phages for Escherichia coli O157:H7 can be suitable candidates either for infection prevention or treatment of infected people.
E. coli O157 phages
More than 60 phages specific for E. coli O157:H7 have been reported (Table 1) . Most of these phages (27) belong to Myoviridae family. Eleven phages belong to Siphoviridae and only 3 phages are from Podoviridae family. The remaining phages have not been classified yet. Sixteen of these phages have full genomic sequences submitted to NCBI.
Prevention of infection
Numbers of E. coli O157:H7 bacteria can be reduced by application of phages on surfaces or addition of phages to animal hides or bodies. This can decrease the numbers of bacteria in foodstuffs and thereby prevent human infections. Experimental in vitro studies to reduce bacterial numbers on surfaces by the use of anti-O157:H7 phages are presented in Table 1 and discussed below.
Application of phages on surfaces and to foodstuffs
Several studies have demonstrated the usefulness of phage application on post-slaughter meat, on working surfaces and to vegetables (Table 1) .
A phage cocktail of pp01, e11/2, and e4/1c phages eliminated efficiently E. coli O157 from meat when incubated at 37°C. For this, 2 × 10 2 E. coli cells were spotted on meat portions. After an hr, 2 × 10 8 PFU phage particles were spotted onto it (O'Flynn et al., 2004) . Hong et al. also used a cocktail of 3 phages (FFH1, FFH2, and FFH3) at multiplicity of infection (MOI) of 1 on contaminated ground beef, spinach and cheese contaminated with 10 7 CFU/mL E. coli O157:H7 bacteria. The results showed that the treatment was effective in reducing bacterial numbers in meat by almost 2 logs and in spinach by over 3 logs when stored 24 h at room temperature, but not in cheese (Hong et al., 2014) .
Stainless steel coupons were immersed in 30 mL of 10 8 CFU/mL of E. coli O157 suspension, and the coupons with an average of 4 × 10 2 CFU attached cells were then immersed in a phage KH1 suspension of 5 × 10 7 PFU/mL. This approach reduced the numbers of E. coli by 1.2 logs during a 1 day exposure (Sharma et al., 2005) . Viazis et al. tested a cocktail of 8 phages (38, 39, 41, AR1, 42 , CEV2, ECB7, ECA1) on stainless steel, ceramic tile, and polyethylene chips. The treatment could significantly reduce bacterial concentrations on these surfaces. They also treated spinach and lettuce with the cocktail alone and in combination with trans-cinnamaldehyde. Although the cocktail was effective in reducing E. coli O157:H7 counts on vegetables, the combination was much more effective and killed bacteria completely. These experiments were carried out by spotting 10 6 PFU phage cocktail on the dried E. coli O157:H7 spots with 10 4 -10 6 CFU (Viazis et al., 2011a (Viazis et al., , 2011b . The contaminated stainless steel, ceramic and plastic sheets were treated with phage PhaxI and showed that the treatment reduced the E. coli O157 contamination by 95-98% (Table 1) . PhaxI also killed E. coli O157 in milk during a 90 minute incubation (Shahrbabak et al., 2013) . Magnone et al. used EcoShield, SalmoFresh, and ShigActive to control E. coli O157:H7, Salmonella, and Shigella spp. on fresh fruits and vegetables (Magnone et al., 2013) . Ecoshield™ (ECP-100) is a FDA-cleared commercial phage cocktail of ECML-4, ECML-117, and ECML-134 bacteriophages and it is used to eliminate or reduce food contamination of E. coli O157:H7 (Carter et al., 2012; Ferguson et al., 2013) . Spraying EcoShield (1 × 10 6 to 5 × 10 6 PFU/g) reduced E. coli numbers by 94% and 87% in beef and lettuce with an E. coli contamination of about 10 3 CFU/g, respectively, during a 5 min contact time (Carter et al., 2012) . Boyacioglu achieved a ca. 2.5 log CFU/cm 2 reduction of bacterial numbers (4.5 log CFU/cm 2 ) on lettuce and spinach by spraying EcoShield (3 × 10 6 PFU/cm 2 ) together with a modified atmosphere packaging (Boyacioglu et al., 2013) . Spray application of EcoShield with high phage concentrations (10 10 and 10 9 PFU/mL) significantly reduced E. coli numbers in contaminated hard surfaces and different food samples (Abuladze et al., 2008) . Immersion of lettuce in 6 × 10 9 PFU/mL EcoShield for 2 min followed by spot inoculation with 1.2 × 10 5 CFU/mL (2.5 × 10 2 CFU/cm 2 ) of E. coli O157:H7 was significantly effective in reduction of the pathogen. However, the low titer phage suspension (2 × 10 8 PFU/mL) was not as effective. Spraying 2 × 10 9 PFU/mL EcoShield after inoculation of 8 × 10 6 CFU/mL E. coli O157:H7 was even more effective than immersion (Ferguson et al., 2013) . EcoShield (10 8 PFU/cm 2 ) was also effective in reducing bacterial numbers on fresh-cut cantaloupes (pipetted phage) and lettuce (sprayed phage) at 4°C inoculated with 6 × 10 3 CFU/cm 2 E. coli O157:H7 (Sharma et al., 2009) . A cocktail of six E. coli O157 specific phages isolated from feedlot by Callaway and coworkers were used by spraying 50 mL of 10 8 PFU/mL suspension on spinach harvester blades contaminated with 7 × 10 4 E. coli O157 bacteria; this treatment was able to kill bacteria on blades during a 2 h incubation (Patel et al., 2011) .
In all studies, the anti-O157:H7 coliphages were effective in eliminating or reducing contamination by this pathogen on surfaces of food and material. However, the rate of elimination was affected by the time and temperature of the incubation and the relative numbers of E. coli O157:H7 and the bacteriophages.
Biocontrol or pre-harvest experiments
Some studies have applied phages to control E. coli O157:H7 numbers in live animals or hides. Theoretically this could decrease the spreading of the pathogen onto food and water, but it has proven to be less efficient than application of phages on surfaces and vegetables.
While it has been convincingly demonstrated that cattle functions as a major E. coli O157:H7 reservoir, the bacterial shedding is periodic with the maximum incidence during summer (Bach et al., 2003) . Therefore, to circumvent the potential problems caused by the erratic nature of the pathogen shedding, many experiments were performed on animals negative for E. coli O157:H7 in feces (Bach et al., 2003; Callaway et al., 2008; Rozema et al., 2009) .
In one study performed with phage DC22 only an extremely high MOI (10 5 PFU/CFU) could decrease the E. coli O157:H7 levels (Table 1) . The experiment was performed in Rusitec (an artificial rumen system) where an inoculation of phage at a MOI of 10 5 PFU/CFU could eliminate10 7 CFU of E. coli O157:H7 from the system within 4 h, although an inoculation of the phage at the same MOI was not effective in reducing 10 8 CFU of E. coli O157:H7 bacteria in sheep feces (Table 1) . Furthermore, in both treated and control lamb groups, the O157:H7 numbers had decreased significantly after 13 days and completely eliminated one month post inoculation (Bach et al., 2003) . Raya et al. showed that a single oral dose of phage CEV1 (~10 11 PFU) could reduce the level of E. coli O157:H7 (~10 10 CFU by oral gavage) by 2 logs in ruminal, cecal, and rectal contents of sheep, demonstrating that in this case the phage was a promising candidate for phage therapy (Raya et al., 2006) . Raya and coworkers also reported a significant (Sheng et al., 2006) e11/2 (112) (Myoviridae) Cattle, orally in combination with e4/1c 10 10 About 10 3 CFU/g feces Not efficient compared to control (Rivas et al., 2010) e4/1c (Siphoviridae) Cattle, orally in combination with e11/2 10 10 About 10 3 CFU/g feces Not efficient compared to control (Rivas et al., 2010) Callaway phages (?) Sheep, orally 10 10~1 0 4 CFU/g feces Efficient compared to control (Callaway et al., 2008) SP21, SP22 (?) Mice, orally (cocktail with SP15) 10 9 Less than 10 2 CFU/g feces Efficient (daily phage administration) (Tanji et al., 2005) SP15 (Syphoviridae) Mice, orally (cocktail with SP21 and SP22) 10 9 Less than 10 2 CFU/g feces Efficient (daily phage administration) (Tanji et al., 2005) rV5, wV7, wV8, wV11 (Myoviridae)
Steer, oral and rectal 5 × 10 10 10 2 -10 3 CFU/g feces (day 12)
Generally not efficient compared to non-treated control (Rozema et al., 2009) ФD, ФW (Myoviridae) Mice, injection alone, orally (ФD) 10 7 0 (for ФD),~10 5 (for ФW)
Efficient after 48 h (Capparelli et al., 2006) Phage with no reported experiments
2003) CBA65 (?)
---- (Viazis et al., 2011a, reduction (99.9%) in E. coli O157:H7 numbers (~10 10 CFU by oral gavage) by using a cocktail of CEV1 and CEV2 (~10 11 PFU) in sheep (Raya et al., 2011) . Administration of 1.3 × 10 11 PFU of KH1 phage orally had no significant effect on bacterial numbers in sheep feces (Table 1) . Using high doses of phage preparations increased the phage PFU in animal feces, but did not reduce E. coli O157 CFU. The authors proposed that this may be related to the nature of the KH1 phage and/or the conditions in the intestinal tract. However, treatment of mice orally with the SH1 phage alone or in combination with KH1 (~10 10 PFU), eliminated the E. coli O157:H7 bacteria from the feces of mice infected with an oral dose of 10 8 CFU. A high titer cocktail of KH1 and SH1 (~10 10 PFU) used at the rectoanal junction in cattle decreased E. coli O157:H7 CFU as well (Sheng et al., 2006) . Callaway et al. used an oral (~10 10 PFU) cocktail of 8 phages isolated from feedlot to treat sheep (Table 1) . They could reduce the bacterial counts from 10 7 CFU/g feces to 10 4 CFU/g feces, but were not able to eliminate the pathogens completely (Callaway et al., 2008; Callaway et al., 2006) .
Using phage e11/2 at MOIs 100 and 1 in a model rumen system inoculated with 10 3 or 10 6 CFU/mL of E. coli O157:H7 reduced significantly the bacterial numbers within 1 h. In the same conditions, e4/1c (MOIs 10 and 1000) reduced bacterial count within 2 h. However, oral doses of bacteriophage cocktail of e11/2 and e4/1c (10 11 PFU) repeated for 3 days could not eliminate E. coli O157 from cattle feces (Table 1) . Although the model rumen results for these two phages seemed promising, in vivo results were not as promising (Rivas et al., 2010) . A cocktail of e11/2 (1 × 10 9 PFU/mL) and e4/1c (1 × 10 10 PFU/mL) phages was also tested on 400 cm 2 cattle hide portions having 1 × 10 6 CFU/cm 2 E. coli O157:H7. The results after immediate sampling showed that this treatment was not more effective than washing with water only. However, when sampling was done after 1 h, the bacterial numbers were significantly lower (1.5 log 10 CFU/cm 2 ) than in water washed samples (Coffey et al., 2011) . Rozema et al. used a cocktail of four anti-O157:H7 coliphages (rV5, wV7, wV8, wV11) orally, rectally, and in a combination of both routes (~10 11 PFU). They found that oral administration of phages was more effective in reducing fecal shedding of E. coli O157:H7 than rectal administration (Rozema et al., 2009). Sheng et al. reported the efficacy of rectal administration of phages to steers. They also used a concentration of~10 6 PFU/mL phages in tested animal drinking water (Sheng et al., 2006) . Rosema et al. suggested that oral administration of phages in drinking water may be the reason of effectiveness of rectal administration of phages in the Sheng et al. paper (Rozema et al., 2009) . In another study, oral administration of a cocktail of phages SP15, SP21, and SP22 (10 10 PFU, daily) in mice enhanced the rate of reduction of bacteria in animal feces compared to groups receiving no phage and a single oral phage dose (Table 1) (Tanji et al., 2005) .
The bacterial surface receptors of anti-O157:H7 phages
The E. coli O157:H7 surface receptors that phages use for adsorption have been characterized for some of the phages. LPS and the outer membrane porins are the most common receptors for phage attachment. LPS is the receptor of the KH1, KH4, and KH5 phages, while phages CEV1 and pp01 bind to OmpA and OmpC, respectively (Kudva et al., 1999; Morita et al., 2002) . It is proposed that OmpC and LPS are both used by the AR1 phage (Yu et al., 2000) . The E. coli ompC mutant was resistant to phage SP21 while LPS mutants were shown to be resistant to phage SP22 (Tanji et al., 2004) . The ferrichrome-iron receptor FhuA has been identified as the receptor for CEV2 (Raya et al., 2011) . The identification of the phage receptors is important since phage resistant mutants are frequently isolated. To prevent this it is recommended to use phages with different receptors in a phage cocktail.
Problems and solutions
Gastrointestinal tract of food animals is an anaerobic environment where E. coli O157:H7, a facultatively anaerobic organism, can survive and grow, however, under tight competition with the gut normal flora. Bacteriophage proliferation is dependent on its host growth rate and it does not take place in non-growing host cells. Also, the ability of the phages to adapt to, and proliferate, under anaerobic conditions should also be taken under consideration. Indeed, it was shown that aeration was important for the elimination of bacteria by the phages from in vitro cultures. In non-aerated samples, bacteria were eliminated only after 5 days and at 4°C (Kudva et al., 1999; Rivas et al., 2010) . Only a few phages have been found to be effective under anaerobic conditions, such as a cocktail of phages EP16, PP17, SP22 that significantly decreased the E. coli O157:H7 numbers in anaerobic condition (Kunisaki and Tanji, 2010) .
The main problem in oral application of phages is acidity and proteolytic activity of the stomach (Ryan et al., 2011) . Most phages are acid-sensitive and cannot tolerate acidic conditions of stomach. Koo et al. used antacid with vibriophages and proposed that antacids increase phage survival in stomach (Koo et al., 2001) . Smith et al. used CaCO 3 to protect phage from stomach acidity (Smith et al., 1987) . Also, the cocktail which Tanji used was not stable at acidic pH, so CaCO 3 was used to prepare the cocktail (Tanji et al., 2005) . Microencapsulation of phage particles in polymers could also be a suitable method to increase phage viability. Chitosan-Alginate microencapsulated Felix O1 (a Salmonella phage) survived much better than free phage under conditions simulating pig gastrointestinal tract . Stanford et al. used phages rV5, wV7, wV8 , and wV11 as a cocktail in methacrylate polymer. The encapsulation was effective in protecting phages from pH of 3 in vitro. However, when used in cattle, the encapsulated phages did not reduce E. coli O157 shedding in feces, but reduced the shedding period (Stanford et al., 2010) . It is recommended in all phage therapy experiments to use a cocktail of phages with different host ranges and different receptors on host to broaden the host range and reduce occurrence of phage resistance in the target organisms (Tanji et al., 2005; Tanji et al., 2004) . 
Conclusions
The isolated phages against pathogenic bacterium E. coli O157:H7 were effective in eliminating or decreasing the number of bacteria in vitro. However, in vivo experiments did not demonstrate such clear efficiency. There are several problems using phages orally and pharmaceutical sciences could introduce novel strategies to solve these problems. The work should be continued as more efficient phage treatment regimens might be found in future. In addition, more studies should be focused on finding active phages in digestive system pH and anaerobic conditions.
